153 related articles for article (PubMed ID: 3978636)
1. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
Blasberg R; Horowitz M; Strong J; Molnar P; Patlak C; Owens E; Fenstermacher J
Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636
[TBL] [Abstract][Full Text] [Related]
2. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
Horowitz M; Blasberg R; Molnar P; Strong J; Kornblith P; Pleasants R; Fenstermacher J
Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
Chapman JD; Baer K; Lee J
Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors.
Wong KH; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):135-43. PubMed ID: 2745188
[TBL] [Abstract][Full Text] [Related]
6. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.
Garrecht BM; Chapman JD
Br J Radiol; 1983 Oct; 56(670):745-53. PubMed ID: 6616139
[TBL] [Abstract][Full Text] [Related]
7. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
Rasey JS; Grunbaum Z; Krohn K; Nelson N; Chin L
Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
[TBL] [Abstract][Full Text] [Related]
8. Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells.
Rasey JS; Krohn KA; Grunbaum Z; Conroy PJ; Bauer K; Sutherland RM
Radiat Res; 1985 Apr; 102(1):76-85. PubMed ID: 3983371
[TBL] [Abstract][Full Text] [Related]
9. In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors.
Procissi D; Claus F; Burgman P; Koziorowski J; Chapman JD; Thakur SB; Matei C; Ling CC; Koutcher JA
Clin Cancer Res; 2007 Jun; 13(12):3738-47. PubMed ID: 17575240
[TBL] [Abstract][Full Text] [Related]
10. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
Akel G; Canal P; Bugat R; Soula G; Combes PF
J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
[TBL] [Abstract][Full Text] [Related]
11. Comparative distribution of misonidazole and its amine metabolite in female Swiss Webster mice.
Born JL; Hadley WM
Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1157-61. PubMed ID: 3997598
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
13. Changes in misonidazole binding with hypoxic fraction in mouse tumors.
Hirst DG; Hazlehurst JL; Brown JM
Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1349-55. PubMed ID: 4008291
[TBL] [Abstract][Full Text] [Related]
14. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
15. Regional measurements of blood flow in experimental RG-2 rat gliomas.
Groothuis DR; Pasternak JF; Fischer JM; Blasberg RG; Bigner DD; Vick NA
Cancer Res; 1983 Jul; 43(7):3362-7. PubMed ID: 6850640
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
[TBL] [Abstract][Full Text] [Related]
17. Distribution of misonidazole adducts in 9L gliosarcoma tumors and spheroids: implications for oxygen distribution.
Franko AJ; Koch CJ; Boisvert DP
Cancer Res; 1992 Jul; 52(14):3831-7. PubMed ID: 1617656
[TBL] [Abstract][Full Text] [Related]
18. [Regional blood flow of experimental brain tumors with special reference to effects of chemotherapy and radiotherapy].
Nagashima T; Matsutani M; Tamura A; Orii H
No To Shinkei; 1985 Mar; 37(3):287-94. PubMed ID: 3860212
[TBL] [Abstract][Full Text] [Related]
19. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
Franko AJ; Chapman JD
Br J Cancer; 1982 May; 45(5):694-9. PubMed ID: 7082555
[TBL] [Abstract][Full Text] [Related]
20. Tissue and tumor distribution of C-penclomedine in rats.
O'Reilly S; Hartman NR; Grossman SA; Strong JM; Struck RF; Eller S; Lesser GJ; Donehower RC; Rowinsky EK
Clin Cancer Res; 1996 Mar; 2(3):541-8. PubMed ID: 9816201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
